Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - sertraline hydrochloride, quantity: 111.92 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 400 - adults: setrona is indicated for the treatment of major depression. setrona is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - sertraline hydrochloride, quantity: 55.96 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 400 - adults: setrona is indicated for the treatment of major depression. setrona is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg;  ;   - film coated tablet - 100 mg - active: sertraline hydrochloride 111.92mg equivalent to sertraline 100 mg     excipient: calcium hydrogen phosphate dihydrate hyprolose magnesium stearate microcrystalline cellulose opadry white oy-s-58910 sodium starch glycolate - setrona is indicated for the treatment of paediatric patients (6- 17 years of age) with ocd. setrona is indicated for the treatment of obsessive-compulsive disorder (ocd).

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg;  ;   - film coated tablet - 50 mg - active: sertraline hydrochloride 55.96mg equivalent to sertraline 50 mg     excipient: calcium hydrogen phosphate dihydrate hyprolose magnesium stearate microcrystalline cellulose opadry white oy-s-58910 sodium starch glycolate - setrona is indicated for the treatment of paediatric patients (6- 17 years of age) with ocd. setrona is indicated for the treatment of obsessive-compulsive disorder (ocd).

Australia - English - Department of Health (Therapeutic Goods Administration)

ranbaxy australia pty ltd - sertraline hydrochloride -

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: nelpa lifesciences, inc.; distributor: kaufmann pharma inc. - ondansetron (as hydrochloride) - solution for injection - 2mg/ml (8mg/4ml) (4mg/2ml)

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

ondansetron 4mg/2ml

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

ondansetron 8mg/4ml

Singapore - English - HSA (Health Sciences Authority)

drug houses of australia private limited - ondansetron hydrochloride (dihydrate) 2.5mg/ml equivalent to ondansetron - injection, solution - 2 mg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

monicopharma limited - ondansetron - tablet - 8 mg